In the IBD colonoids, LPS treatment increased the expression of the EIF3F, ANXA1, SF3A1, and LOC111092171 genes, whereas it decreased their expression in the IBD enteroids (Figure 10). Here, EIF3F is linked to inflammatory bowel disease.